External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Ophthalmology EURETINA 2022
Roche and Genentech at

EURETINA 2022

September 01 - September 04
Hamburg, Germany / Virtual (Hybrid)
euretina.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
10:30 AM
Duration 4mins Virtual
Anti–vascular endothelial growth factor treatment intervals and visual outcomes in patients with diabetic macular edema: analysis from 4 National Health Service centres in the United Kingdom
Ghanchi F, Peto T, Talks S J, Chuo J, Ferrara D, Spicer,G Balasubramanian S, Chi G
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 4mins Virtual
Characterising Anti–Vascular Endothelial Growth Factor (VEGF) Treatment Patterns for Neovascular Age-Related Macular Degeneration in the United Kingdom
Fenech M, Jain M, Cantrell R, Chidambaram J, Judge D, Dodds M, McGrory S, Bailey C
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 4mins Virtual
Clinical Trial Versus Real-world Outcomes With Anti-VEGF Therapy for Branch and Central Retinal Vein Occlusion
Baumal C, Danzig C, Blotner S, Steffen V, Haskova Z
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
4mins Virtual
Faricimab in neovascular age-related macular degeneration (nAMD): efficacy, safety, and durability through week 48 in the phase 3 TENAYA and LUCERNE trials
Cheung CMG, Guymer R, Demetriades AM, Margaron P, Quezada Ruiz C, Silverman D, Ives J, Basu K, Souverain A, Yang M, Lin H
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 5mins Virtual
Long-term Safety and Efficacy of the Port Delivery System With Ranibizumab in Neovascular Age-Related Macular Degeneration: Interim Analysis of the Portal Extension Trial
Eter N, Eichenbaum D, Callaway N, Morral M, Smith R, Campochiaro P
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
09:02 AM
Duration 6mins Congress Center Hamburg, Germany
Patient Experience with Anti-VEGF Intravitreal Injections in Neovascular Age-related Macular Degeneration and Diabetic Macular Edema: A Multinational Observational Study
Giocanti A, Holekamp N, Sheeth V, Peto T, Kertes P, Layana AG, Viola F, Barbier V, Lewis H, Lambert J, Gentile B, Chi G, Mirt M
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
11:14 AM
Duration 6mins Congress Center Hamburg, Germany
End-of-Study Retinal Fluid and Vision Outcomes in the Phase 3 Archway Trial of the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration
Rachitskaya A, Blotner S, Heinrich D, Gune S
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
11:32 AM
Duration 6mins Congress Center Hamburg, Germany
Faricimab in Neovascular Age-Related Macular Degeneration: Year 2 Patient Case Profiles From the Phase 3 TENAYA and LUCERNE Trials
Figueroa M, Pearce I, Demetriades AM, Kotecha A, Silverman D, Swaminathan B, Patel V, Lin H
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 6mins Congress Center Hamburg, Germany
Faricimab in Neovascular Age-Related Macular Degeneration: 48-Week Results by Dosing Interval Cohort in the Phase 3 TENAYA and LUCERNE Trials
Lai T, Michels S, Demetriades AM, Quezada Ruiz C, Silverman D, Ives J, Swaminathan B, Lin H
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
12:23 PM
Duration 6mins Congress Center Hamburg, Germany
Personalised Treatment Interval (PTI) Dosing Dynamics Over 2 Years in the Phase 3 YOSEMITE and RHINE Trials of Faricimab in Diabetic Macular Edema
Korobelnik JF, Jaffe GJ, Gerendas BS, Abreu F, Camino A, Jain N, Tang Y, Haskova Z
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
12:29 PM
Duration 6mins Congress Center Hamburg, Germany
Angiopoietin-2 signalling and vascular stability with faricimab in diabetic macular edema
Joussen A, Willis JR, Haskova Z, Westenskow PD, Lin H
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
12:35 PM
Duration 6mins Congress Center Hamburg, Germany
Predicting 5-year progression to vision-threatening complications using machine learning
Cunha-Vaz J, Dampolous D, Mendes L, Santos T, Neubert A, Ferrara D, Benmansour F
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
12:53 PM
Duration 6mins Congress Center Hamburg, Germany
VOYAGER: An Innovative, Global, Observational Study to Gain Real-world Insights Into the Long-term Utilisation of the Port Delivery System With Ranibizumab and Faricimab for the Treatment of nAMD and DME
Guymer R, Bailey C, Chaikitmongkol V, Chakravarthy U, Chaudhary V, Finger R, Gallego R, Koh A, Lövestam M, Parravano M, Luna Pinto JD, Schmitz-Valckenberg MS, Sheth V, Souied E, Chi G, Glittenberg C, Scheidl S, Bengus M
Ophthalmology | Neovascular Age Related Macular Degeneration - Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
01:05 PM
Duration 6mins Congress Center Hamburg, Germany
Deep Learning Model to Identify Moderately Severe and Severe Non-proliferative Diabetic Retinopathy From 7-Field Colour Fundus Photographs
Cunha-Vaz J, Dampoloulos D, Yang Q, Neubert A, Mendes L, Santos T, Sredar N, Ferrara D, Benmansour F
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
01:23 PM
Duration 6mins Congress Center Hamburg, Germany
Faricimab in Neovascular Age-Related Macular Degeneration: Year 2 Efficacy, Safety, and Durability Results From the Phase 3 TENAYA and LUCERNE Trials
Holz F, Khanani A, Demetriades A-M, Kotecha A, Silverman D, Swaminathan B, Patel V, Lin H
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
01:45 PM
Duration 5mins Hamburg, Germany / Virtual (Hybrid)
View the EURETINA 2022 symposium on Advancing the management of nAMD: Latest clinical insights from targeting Ang-2/VEGF-A via dual inhibition
Holz F, Cheung G, Tadayoni R and Khanani AM
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:29 PM
Duration 6mins Congress Center Hamburg, Germany
Key Clinical Pearls for Evaluating Surgical Candidates, and Patient Preference, for the Port Delivery System With Ranibizumab
Figueroa M, Holekamp N, Bobbala A, Callaway N, DeGraaf S, Menezes A, Heinrich D
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:35 PM
Duration 6mins Congress Center Hamburg, Germany
Central Subfield Thickness Fluctuations and Their Impact on Vision Outcomes Over 96 Weeks in the Archway Trial of the Port Delivery System With Ranibizumab (PDS)
Chakravarthy U, Blotner S, Heinrich D, Gune S, Sheth V
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:41 PM
Duration 6mins Congress Center Hamburg, Germany
Key Pearls of the Refill-Exchange Procedure for the Port Delivery System With Ranibizumab
Khanani A, Singh N, Barteselli G, Callaway N, Patel S, Jaycock P, Menezes A, Malhotra V
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
04:27 PM
Duration 6mins Congress Center Hamburg, Germany
Efficacy, Durability and Safety of Faricimab in Diabetic Macular Edema: 2-Year Results From the Phase 3 YOSEMITE and RHINE Trials
Schlottmann PG, Wells JA, Haskova Z, Mohan S, Silverman D, Tang Y, Lin H
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
04:32 PM
Duration 6mins Congress Center Hamburg, Germany
HONU: A Multicenter, Prospective, Observational Study of the Progression of Intermediate Age-Related Macular Degeneration
Guymer R, Wu Z, Datta S, Steffen V, Gao S, Zhang M, Litts KM, Chang MC, Elstrott J, Zhang J, Liu L, Willis J, Chen H
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
05:08 PM
Duration 6mins Congress Center Hamburg, Germany
Archway Phase 3 Trial of the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration: End-of-Study Results
Rizzo S, Brooks L, Mittra R, Wykoff C, Callaway N, DeGraaf S, Fung AE, Gune S, LePogam S, Smith R, Willis J, Barteselli G
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
05:14 PM
Duration 6mins Congress Center Hamburg, Germany
Key Surgical Pearls for Best Practice During the Port Delivery System With Ranibizumab (PDS) Implant Insertion Procedure
Becker M, Sheth V, Callaway N, Malhotra V, Menezes A, Singh N, Jaycock P
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
05:45 PM
Duration 5mins Hamburg, Germany / Virtual (Hybrid)
View the EURETINA 2022 symposium on Expert clinical insights: How continuous delivery of anti-VEGF is changing the management of nAMD
Wolf A, Figueroa MS and Khanani AM
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
01:45 PM
Duration 5mins Hamburg, Germany / Virtual (Hybrid)
View the EURETINA 2022 symposium on Broadening management options for DME: Recent clinical insights from targeting dual inhibition of Ang-2 and VEGF-A
Korobelnik J-F, Wong TY, Westenskow P, and Holekamp N
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:12 PM
Duration 5mins Congress Center Hamburg, Germany
Quantification of Lesion Progression of Incomplete and Complete Retinal Pigment Epithelium and Outer Retinal Atrophy in Age-Related Macular Degeneration
Schmitz-Valckenberg S, Sassmannshausen M, Braun M, Steffen V, Gao S, Honigberg L, Ferrara D, Pfau M, Holz
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.